Skip to content

Use of Kalajaji and Rasna churna with Basti and yogic practices in primary dysmenorrhoea (kashtartava)

A comparative study on effect of Kalajaji and Rasna churna along with Basti and selected yogic practices in primary dysmenorrhoea (kashtartava)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042602
Enrollment
50
Registered
2022-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system Health Condition 2: N944- Primary dysmenorrhea Health Condition 3: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

FACULTY OF AYURVEDA INSTITUTE OF MEDICAL SCIENCES BANARAS HINDU UNIVERSITY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate in study. Age group between 14 to 45 years,(11 to 13 years of age girls will not be the part of research work because of fear of therapies in them). Unmarried and married both patients attending the OPD with chief complain of Primary Dysmenorrhea (kashtartava) with scanty or average amount of menses along with associated symptoms without any organic pathology. Patients suffering for more than two cycles.

Exclusion criteria

Exclusion criteria: 1.Patients below 14 years and above 45 years. Any abnormalities detected in investigation (routine and specific). 2.Coagulation disorders. 3.Patients suffering from chronic systemic disease like uncontrollable diabetes, uncontrollable hypertension, venereal disease, thyroid dysfunction, renal diseases, jaundice or any disorder influencing general physical health and ultimately influencing menses. 4.Patients using IUCD & OCPs or injectables contraceptives & others. 5.Patients with any history of allergy or allergy from trial drugs. 6.Patients having Central nervous system disorders like epilepsy, meningitis, migraine or any other psychological disorders. 7.Patients having Respiratory disorders like bronchial asthma, tuberculosis, pneumonia, pleural effusion, bronchitis & others. 8.Patients suffering from cardiac disorders like angina, myocardial infarction, congenital anomalies of heart & others.ï?§ Patients having gastrointestinal disoders like appendicitis, cholecystitis, hepatitis, pancreatitis, cholelithiasis, diverticulutis, gastric ulcer, irritable bowel syndrome & others. 9.Patients having organic pelvic pathology, benign and malignant tumors of vulva, vagina, rectum, cervix, uterus, PID, congenital anomalies of genital tract and different type of infections of genital tract. 10.Patient having breast carcinoma. 11.Patient is on chemotherapy/radio therapy for any malignant condition of any organ.

Design outcomes

Secondary

MeasureTime frame
Improvement in criteria listed in different scalesTimepoint: Total four (4) follow-ups will be done at regular interval of one month before 10 days prior to expected date of menses for 4 consecutive cycles, Three (3) follow ups will be done with medication and one (1) without medication to see the changes in parameters

Primary

MeasureTime frame
Assessment will be done on the basis of prepared proforma and improvement in sign and symptoms of kashtartavaTimepoint: 4 month (3 month with medication and 1 month without medication)

Countries

India

Contacts

Public ContactDR POONAM PRAJAPATI

INSTITUTE OF MEDICAL SCIENCES BANARAS HINDU UNIVERSITY

ssom18@gmail.com7607165096

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026